期刊文献+

测定肾动脉狭窄患者尿微球蛋白的临床意义

Clinical significance of urine microglobulin in patients with renal artery stenosis(RAS)
下载PDF
导出
摘要 目的 评价测定肾动脉狭窄患者尿微球蛋白的临床意义。方法 根据肾动脉造影结果 ,将 12 1例入选患者分为严重狭窄组 (肾动脉内径减少 >70 % ) 5 2例 ,轻度狭窄组 (内径减少 <70 %但 >5 0 % ) 3 1例及对照组 3 8例。测定各组尿α1 微球蛋白 (α1 MG )和 β2 微球蛋白 ( β2 MG)。结果 严重狭窄组患者尿 β2 MG较轻度狭窄组及对照组显著升高 (P <0 .0 0 1)。经多因素统计分析后 ,尿 β2 MG升高与严重肾动脉狭窄 (P =0 .0 0 0 )、左室射血分数减低 ( <0 .5 )、糖尿病、服用钙离子拮抗剂与利尿剂等因素相关。严重狭窄组尿α1 MG较其他 2组升高 (P =0 .0 12 ) ,但未高于正常上限。结论 尿 β2 MG较血清肌酐更能反映早期肾脏缺血。严重肾动脉狭窄 ( >70 % )患者多伴尿微球蛋白升高 ,提示合并肾小管功能障碍。 Objective To evaluate clinical significance of urine microglobulin in patients with renal artery stenosis(RAS).Methods According to the results of renal artery angiography,121 patients were divided into 3 groups,including 52 patients with severe RAS(lumen narrowing >70%,Group I),31 patients with mild RAS(lumen narrowing 50% ~70%,Group II) and 38 healthy people(control group).The urine α1,β2-microglobulin(MG) were recorded respectively among 3 groups.Results The urine β2-MG in group I were significantly increased compared with the other two groups(P<0.001).According to multinomial logistic regression,elevation of urine β2-MG was related to low LVEF(<0.50),diabetes,administration of CCB and diuretics.Urine α 1-MG of group I were slightly increase compared with the other two groups(P=0.012).Conclusions Urine β2-MG is a specific factor to predict renal ischemia in early stage.Severe RAS causes damage of tubular reabsorption.In patients with abnormal urine microglobulin,renal artery intervention should be performed in early stage.
出处 《临床内科杂志》 CAS 北大核心 2004年第2期99-101,共3页 Journal of Clinical Internal Medicine
关键词 动脉粥样硬化 肾动脉狭窄 微球蛋白 Atherosclerosis Renal artery stenosis Microglobulin
  • 相关文献

参考文献2

二级参考文献18

  • 1胡大一 李田昌 等.心脏及血管疾病的现代治疗[J].中国医药导刊,2000,9:73-76.
  • 2[1]Safian RD,Textor SC.Renal-artery stenosis.N Engl J Med,2001,344:431-442.
  • 3[2]Jean WJ,al-Bitar I,Zwicke DL,et al.High incidence of renal artery stenosis in patients with coronary artery disease.Cath Cardiovasc Diagn,1994,32:8-10.
  • 4[3]Radermacher J,Chavan A,Bleck J,et al.Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis.N Engl J Med,2001,334:410-417.
  • 5[4]Cambria RP.Surgery: Indications and variables that affect procedural outcome,as well as morbidity and mortality.J Invas Cardiol,1998,10:55-58.
  • 6[5]Hansen KJ,Lundberg AH,Benjamin ME,et al.Is renal revascularization in diabetic patients worthwhile.J Vas Surg,1996,24:383-393.
  • 7[6]Van de Ven PJG,Beutler JJ,Kaatee R,et al.Transluminal vascular stent for ostial atherosclerotic renal artery stenosis.Lancet,1995,346:672-674.
  • 8[7]Dorros G,Jaff M,Mathiak L,He TH,and multicenter participants.Multicenter Palmaz stent renal artery stenosis revascularization registry report: 4-year follow-up of 1058 successful patients.In Henry M,Amor M.Tenth interventional course book of peripheral vascular intervention.1999,399-406.
  • 9[8]Zeller T,Tubler T.Endovascular treatment of renal artery stenosis.In Marco J,Serruys P,Biamino G et al.The Paris course on revascularization.2002,383-409.
  • 10杨进刚.RAS的血管成形技术[J].中国医药导刊,2000,(2):148-148.

共引文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部